Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)
SAN DIEGO, May 20, 2016 -- (Healthcare Sales & Marketing Network) -- Otonomy, Inc. (OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that t... Biopharmaceuticals, ReimbursementOtonomy, OTIPRIO, ciprofloxacin otic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 20, 2016 Category: Pharmaceuticals Source Type: news
Physicians React to New FDA Warning on Cipro, Similar Drugs
(MedPage Today) -- Experts discuss FDA warning, impact, and other drug choices (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 18, 2016 Category: American Health Source Type: news
Otovel (Ciprofloxacin and Fluocinolone Acetonide Otic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 18, 2016 Category: Drugs & Pharmacology Source Type: news
FDA Calls for More Restrictions on Fluoroquinolone Use (FREE)
By Kristin J. Kelley
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
The risks for "disabling and potentially permanent" side effects associated with systemic fluoroquinolone antibacterials (e.g., ciprofloxacin, moxifloxacin) generally outweigh the benefits in patients with … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 15, 2016 Category: Primary Care Source Type: news
D.C. Week: Federal Judge Rules Against ACA Subsidies
(MedPage Today) -- FDA warns that Cipro and similar antibiotics should not be used for uncomplicated infections (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 14, 2016 Category: Psychiatry Source Type: news
FDA: Cipro side effects outweigh benefit for some infections
NEW YORK (AP) — The U.S. Food and Drug Administration is ratcheting up its warning about the potential side effects of a type of commonly-prescribed powerful antibiotic often known by the brand name Cipro. (Source: U.S. News - Health)
Source: U.S. News - Health - May 13, 2016 Category: Consumer Health News Source Type: news
FDA: Avoid Cipro, Similar Drugs for Common Infections
(MedPage Today) -- Agency says risks outweigh benefits (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 12, 2016 Category: American Health Source Type: news
Preventing Medication Errors: Lessons From a Patient
A Nurse Aide, an Emergency Room Clerk, and a Patient
I have great appreciation for doctors and nurses, hospitals, and patients. In high school I worked as a nurse aide in a convalescent home. I fed, dressed, and showered elderly patients, many of them immobile. I shaved gentlemen's facial stubble and polished ladies' fingernails. In college and in graduate school, I worked as an emergency room clerk. I witnessed a lot, including amazing doctors and nurses caring for patients and saving lives. I have also been a patient. First, when I had an appendectomy at age eight and then when I gave natural childbirth twice. All were...
Source: Healthy Living - The Huffington Post - May 2, 2016 Category: Consumer Health News Source Type: news
Digital Attraction
From its formation in 1863, Bayer AG has been a hugely influential and innovative chemical, scientific and pharma company, developing aspirin in 1899 and popularizing the pill, as a form of contraception, in the 1960s. More recently, it introduced the top-selling, second-generation quinolone antibiotic, Cipro, plus anti-cancer drug Nexavar. But to ensure its future is as bright as its past – and keep it at the forefront of pharma – Bayer is wholeheartedly embracing cutting-edge technology and is going digital.
However, when your organization was founded over 150 years ago and is a huge multinational with over 120,000 e...
Source: EyeForPharma - April 26, 2016 Category: Pharmaceuticals Authors: Women in Pharma Source Type: news
Order Permitting Emergency Dispensing of Oral Formulations of Ciprofloxacin and Waiver of CGMP (Current Good Manufacturing Practice) Requirements During an Anthrax Emergency
U.S. Food and Drug Administration. 04/13/2016This six-page document is the order to permit emergency dispensing of Food and Drug Administration-approved oral dosage forms of ciprofloxacin products ("eligible ciprofloxacin products") for the post-exposure prophylaxis of inhalational anthrax during an emergency involving Bacillus (B.) anthracis, the biological agent that causes anthrax disease. It will allow stakeholders to implement plans for emergency dispensing of eligible ciprofloxacin products without individual prescriptions in the future if they reasonably believe there is a need to do so because of their constituents...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 15, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news
Antibiotics Side Effects on the Mitochondria
Science is just beginning to understand how important your mitochondria are to warding off the diseases of aging. And, as usual, mainstream medicine is lagging way behind.
Along with your telomeres, the cellular time keepers at the ends of your chromosomes, your mitochondria are another key component of the anti-aging equation.
You see, these tiny organelles in your cells are the power plants that turn fuel into energy for your body. Healthy mitochondria keep you young and energetic.
Research shows that damaged mitochondria can lead to:
Schizophrenia and bipolar disorder;
Alzheimer’s and Parkinson’...
Source: Al Sears, MD Natural Remedies - March 25, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Natural Cures Source Type: news
You Need to Know: Where the 2016 Presidential Candidates Stand on Food Policy
At this point in the campaign race, we know the candidates' beliefs on issues like war, immigration and Wall Street. But what about food? I wrangled all the information I could find--from tweets to votes--to see where the candidates stand on issues of food policy. Keep in mind, I'm not saying who's right or wrong, just pulling together quotes and votes to help us understand how each candidate views the issues. If I have noted "No public comment available" but you know of a public comment, please add it to the comments below with a link to the original source. Hillary Clinton On food security: Clinton has tweeted: "W...
Source: Science - The Huffington Post - February 18, 2016 Category: Science Source Type: news
Common Antibiotics May Cause Delirium, Confusion And Hallucinations
I have long had severe reservations about quinolone antibiotics, like Levaquin and Cipro. I have had these concerns since I conducted clinical trials to test new antibiotics (including a variety of quinolones) before they went to market. Now I have further concerns about them because of their overuse as an alternative to busy physicians trying to puzzle out what’s wrong with the patient, and because practice “guidelines” promote their overuse. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 18, 2016 Category: Pharmaceuticals Authors: Judy Stone Source Type: news
Ciprofloxacin Resistance in E. coli Urinary Tract InfectionsCiprofloxacin Resistance in E. coli Urinary Tract Infections
How prevalent is ciprofloxacin resistance in E. coli UTIs? BMC Infectious Diseases (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 17, 2016 Category: Pathology Tags: Infectious Diseases Journal Article Source Type: news
Otonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss
SAN DIEGO, Jan. 26, 2016 -- (Healthcare Sales & Marketing Network) -- Otonomy, Inc. (OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced the p... Biopharmaceuticals, OncologyOtonomy, Dexamethasone, Cisplatin-Induced Hearing Loss, ciprofloxacin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 26, 2016 Category: Pharmaceuticals Source Type: news
